Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2010-09-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2010.07.081PMID 20659426PMCID PMC2977999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells

  2009cited by this paper
• Alzheimer Disease Aβ Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts*

  2009cited by this paper
• Lovastatin inhibits amyloid precursor protein (APP) β‐cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts

  2008cited by this paper
• Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.

  2008cited by this paper
• Mechanisms of Disease: new therapeutic strategies for Alzheimer's disease—targeting APP processing in lipid rafts

  2007influential reference
• AMP-activated protein kinase as a drug target.

  2007cited by this paper
• AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

  2007influential reference
• AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model

  2006cited by this paper
• Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction

  2006cited by this paper
• Prevalence of overweight and obesity in the United States, 1999-2004.

  2006cited by this paper
• A lipid boundary separates APP and secretases and limits amyloid β-peptide generation

  2004influential reference
• Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis.

  2003cited by this paper
• The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity

  2003cited by this paper
• Withdrawal: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis

  2003cited by this paper
• Cholesterol, lipid rafts, and disease.

  2002cited by this paper
• The AMP‐activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes

  2001influential reference
• AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation

  2001cited by this paper
• Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes

  2000cited by this paper
• Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

  1998cited by this paper
• Characterisation of 5'-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5'-AMP analogues on enzyme activity.

  1994cited by this paper

• Isoform-specific roles and overlooked complexity of AMPKα in Alzheimer's disease

  2026cites this paper
• Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes.

  2025cites this paper
• Delphinidin attenuates cognitive deficits and pathology of Alzheimer’s disease by preventing microglial senescence via AMPK/SIRT1 pathway

  2025cites this paper
• Research Progress of the AMPK/PINK1/Parkin Pathway in Alzheimer’s Disease Mechanism and Therapeutic Potential

  2025cites this paper
• AMPKα2 signals amino acid insufficiency to inhibit protein synthesis.

  2025cites this paper
• The role of AMPKα subunit in Alzheimer's disease: In-depth analysis and future prospects

  2024cites this paper
• Unveiling the Interplay of AMPK/SIRT1/PGC-1α axis in Brain Health: Promising Targets Against Aging and NDDs.

  2024cites this paper
• Phosphoproteome Microarray Analysis of Extracellular Particles as a Tool to Explore Novel Biomarker Candidates for Alzheimer’s Disease

  2024cites this paper
• Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action.

  2024cites this paper
• Neuronal ablation of GHSR mitigates diet-induced depression and memory impairment via AMPK-autophagy signaling-mediated inflammation

  2024cites this paper
• Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective.

  2024cites this paper
• Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease

  2024cites this paper
• Hearing Loss and Alzheimer Disease.

  2024cites this paper
• Exploring the molecular mechanisms underlying neuroprotective effect of ellagic acid in okadaic acid-induced Alzheimer’s phenotype

  2024cites this paper
• SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system

  2024cites this paper
• Effects of C-Terminal-Ethyl-Esterification in a Snake-Venom-Based Peptide Against the Neurotoxicity of Acrolein in PC12 Cells

  2023cites this paper
• The development and benefits of metformin in various diseases

  2023cites this paper
• Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer’s Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention

  2023cites this paper
• Cellular and Molecular Regulation of Exercise—A Neuronal Perspective

  2022cites this paper
• Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling

  2021cites this paper
• The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease.

  2021cites this paper
• AMPK activators for the prevention and treatment of neurodegenerative diseases

  2021cites this paper
• Gum Arabic supplementation prevents loss of learning and memory through stimulation of mitochondrial function in the hippocampus of type 2 diabetic rats

  2021cites this paper
• Nmnat2 attenuates amyloidogenesis and up-regulates ADAM10 in AMPK activity-dependent manner

  2021cites this paper
• Research Progress on Alzheimer's Disease and Resveratrol

  2020cites this paper
• Metformin use in elderly population with diabetes reduced the risk of dementia in a dose-dependent manner, based on the Korean NHIS-HEALS cohort.

  2020cites this paper
• Upregulation of AMPK Ameliorates Alzheimer’s Disease-Like Tau Pathology and Memory Impairment

  2020cites this paper
• The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence

  2020cites this paper
• Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer’s Disease: A Pilot Study

  2020cites this paper
• AMPK: Potential Therapeutic Target for Alzheimer's disease.

  2020cites this paper
• Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease

  2019cites this paper
• Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development

  2019cites this paper
• An analog derived from phenylpropanoids ameliorates Alzheimer's disease-like pathology and protects mitochondrial function.

  2019cites this paper
• Hearing loss and Alzheimer's disease: A Review.

  2019cites this paper
• Protective effects of fusidic acid against sodium nitroprusside-induced apoptosis in C6 glial cells.

  2019cites this paper
• Physical Activity Alleviates Cognitive Dysfunction of Alzheimer’s Disease through Regulating the mTOR Signaling Pathway

  2019cites this paper
• Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure

  2019cites this paper
• Rôle de la dérégulation neuronale de la protéine kinase activée par l’AMP (AMPK) dans la pathologie tau, l’intégrité des synapses et le métabolisme énergétique : relevance pour la maladie d’Alzheimer

  2018cites this paper
• Cognitive Decline, Dementia, Alzheimer’s Disease and Presbycusis: Examination of the Possible Molecular Mechanism

  2018cites this paper
• Dihydromyricetin Inhibits Lead-Induced Cognitive Impairments and Inflammation by the Adenosine 5'-Monophosphate-Activated Protein Kinase Pathway in Mice.

  2018cites this paper
• Mechanisms of activation and inhibition of the metabolic regulator AMP-activated protein kinase (AMPK)

  2018cites this paper
• Treadmill exercise ameliorates the regulation of energy metabolism in skeletal muscle of NSE/PS2mtransgenic mice with Alzheimer’s disease

  2017cites this paper
• Investigation of the Nrf2-Mediated inhibition of neuroinflammation by diosgenin

  2017cites this paper
• Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase.

  2017cites this paper
• Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism

  2017cites this paper
• Geniposide attenuates the level of Aβ1–42 via enhancing leptin signaling in cellular and APP/PS1 transgenic mice

  2017cites this paper
• Treadmill exercise ameliorates the regulation of energy metabolism in skeletal muscle of NSE/PS2m-transgenic mice with Alzheimer's disease.

  2017cites this paper
• Dissecting the role of AMP-activated protein kinase in human diseases

  2017cites this paper
• Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots

  2017cites this paper
• AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives.

  2016cites this paper
• AMPK in the central nervous system: physiological roles and pathological implications

  2016cites this paper
• AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo

  2016cites this paper
• AMPK in Neurodegenerative Diseases.

  2016cites this paper
• Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a Diverse Therapeutic Target: A Computational Perspective

  2016cites this paper
• Beneficial Effect of Flavone Derivatives on Aβ-Induced Memory Deficit Is Mediated by Peroxisome Proliferator-Activated Receptor γ Coactivator 1α

  2015cites this paper
• Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

  2015cites this paper
• Metformin: repurposing opportunities for cognitive and mood dysfunction.

  2015cites this paper
• Activation of mTOR: a culprit of Alzheimer’s disease?

  2015cites this paper
• Activation of the 5′-AMP-Activated Protein Kinase in the Cerebral Cortex of Young Senescence-Accelerated P8 Mice and Association with GSK3β- and PP2A-Dependent Inhibition of p-tau396 Expression

  2015cites this paper
• Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation*

  2015cites this paper
• Glucose regulates amyloid β production via AMPK

  2015cites this paper
• AMP‐Activated Protein Kinase (AMPK) as a Cellular Energy Sensor and Therapeutic Target for Neuroprotection

  2015cites this paper
• Discovery and characterization of novel drugs for Treatment of Alzheimer disease from a high-throughput compound screen

  2014cites this paper
• The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

  2014cites this paper
• Autophagy dysfunction and its link to Alzheimer's disease and type II diabetes mellitus.

  2014cites this paper
• Adaptive and regulatory mechanisms in aged rats with postoperative cognitive dysfunction

  2014cites this paper
• Senescence-AcceleratedMice P 8 : A Tool to Study Brain Aging and Alzheimer ’ s Disease in aMouseModel

  2014cites this paper
• Monosodium glutamate neurotoxicity increases beta amyloid in the rat hippocampus: a potential role for cyclic AMP protein kinase.

  2014cites this paper
• Effects of Long-Term Treatment with Quercetin on Cognition and Mitochondrial Function in a Mouse Model of Alzheimer’s Disease

  2014cites this paper
• Perspectives of drug-based neuroprotection targeting mitochondria.

  2014cites this paper
• Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome

  2014cites this paper
• Mitochondrial diseases of the brain.

  2013cites this paper
• Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice

  2013cites this paper
• Nucleotide regulation of AMP-activated protein kinase

  2013influential citation
• Contributions of AMP kinase to the Pathogenesis of Type 2 Diabetes and Neurodegenerative Diseases

  2013cites this paper
• Lipid raft disarrangement as a result of neuropathological progresses: a novel strategy for early diagnosis?

  2013cites this paper
• Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites.

  2013cites this paper
• AMPK activation—protean potential for boosting healthspan

  2013cites this paper
• Function of the master energy regulator adenosine monophosphate‐activated protein kinase in stroke

  2013cites this paper
• The Mechanism of Autophagy Regulation and The Role of Autophagy in Alzheimer′s Disease*: The Mechanism of Autophagy Regulation and The Role of Autophagy in Alzheimer′s Disease*

  2012cites this paper
• Senescence-Accelerated Mice P8: A Tool to Study Brain Aging and Alzheimer's Disease in a Mouse Model

  2012cites this paper
• AMP-Activated Protein Kinase (AMPK) and Energy-Sensing in the Brain

  2012cites this paper
• Energy dysfunction in Huntington's disease: insights from PGC-1a, AMPK, and CKB

  2012cites this paper
• Roles of AMP-activated Protein Kinase in Alzheimer’s Disease

  2012cites this paper
• Down-Regulation of Amyloid-β Through AMPK Activation by Inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 Cells

  2012cites this paper
• Energy dysfunction in Huntington’s disease: insights from PGC-1α, AMPK, and CKB

  2012cites this paper
• Bioenergy sensing in the brain

  2011cites this paper
• AMP‐activated protein kinase: a potential player in Alzheimer’s disease

  2011influential citation